Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL208388

CC(C)CC(N)C(=O)O.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 3/20 0.76
ALPI P09923 1/20 0.76
PKM P14618 1/20 0.76
PTGS1 P23219 1/20 0.76
XIAP P98170 1/20 0.76
ANPEP P15144 2/20 0.66
RNPEP Q9H4A4 2/20 0.66
DNPEP Q9ULA0 2/20 0.66
SLC1A3 P43003 3/20 0.65
SLC1A2 P43004 3/20 0.65
SLC1A1 P43005 2/20 0.65
LTA4H P09960 1/20 0.61
SLC15A1 P46059 1/20 0.51
NOS3 P29474 1/20 0.51
NOS1 P29475 1/20 0.51
NOS2 P35228 1/20 0.51
TAAR1 Q96RJ0 2/20 0.50
MAOA P21397 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL2634732 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
D-Phenylalanine SCHEMBL10775923 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL27551454 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL31087886 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL208389 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL10945389 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL28157585 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL15323535 0.98 SLC7A5 (0.73) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL15323532 0.98 SLC7A5 (0.73) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL8532962 0.97 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990654-B1 MODIFIED MONOOXYGENASES FOR THE MANUFACTURE OF HYDROXYLATED AROMATIC HYDROCARBONS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-10-04 EP claimed
EP-3990654-A1 MODIFIED MONOOXYGENASES FOR THE MANUFACTURE OF HYDROXYLATED HYDROCARBONS Covestro Intellectual Property GmbH & Co. KG (DE) 2022-05-04 EP claimed
WO-2020260119-A1 MODIFIED MONOOXYGENASES FOR THE MANUFACTURE OF HYDROXYLATED HYDROCARBONS COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2020-12-30 WO claimed
US-10414815-B2 scFV antibody library ALLIGATOR BIOSCIENCE AB (SE) 2019-09-17 US claimed
CN-109402074-A Monooxygenase mutant and its application 凯莱英医药集团(天津)股份有限公司 2019-03-01 CN claimed
CN-105367601-A Curcumin derivative and preparation method therefor UNIV SHANDONG 2016-03-02 CN claimed
EP-1084137-A1 PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2001-03-21 EP claimed
WO-1999064442-A1 PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) 1999-12-16 WO claimed
CN-1232504-A 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of order designated mononegavirales AMERICAN CYANAMID CO (US) 1999-10-20 CN claimed
EP-0932684-A2 3' GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES AMERICAN CYANAMID COMPANY (US) 1999-08-04 EP claimed
WO-1998013501-A2 3' GENOMIC PROMOTER REGION AND POLYMERASE GENE MUTATIONS RESPONSIBLE FOR ATTENUATION IN VIRUSES OF THE ORDER DESIGNATED MONONEGAVIRALES AMERICAN CYANAMID COMPANY (US) 1998-04-02 WO claimed
CN-1068335-A C type hepatitis diagnosis preparation and vaccine LUCKY LTD (KR) 1993-01-27 CN claimed
CN-117877567-A Metabolic marker for clinical early diagnosis of smoke disease and application thereof 河南省人民医院 2024-04-12 CN disclosed
EP-3990654-B1 MODIFIED MONOOXYGENASES FOR THE MANUFACTURE OF HYDROXYLATED AROMATIC HYDROCARBONS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2023-10-04 EP disclosed
US-20230212680-A1 NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF FALINI BRUNANGELO (IT) 2023-07-06 US disclosed
US-11674161-B2 Modified monooxygenases for the manufacture of hydroxylated hydrocarbons COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-06-13 US disclosed
EP-0572478-A4 A METHOD FOR THE DIAGNOSIS AND TREATMENT OF GLUTAMIC ACID DECARBOXYLASE AUTOANTIGEN ASSOCIATED DISEASES AMRAD CORP LTD (AU) 1994-05-18 EP disclosed
EP-0572478-A1 A METHOD FOR THE DIAGNOSIS AND TREATMENT OF GLUTAMIC ACID DECARBOXYLASE AUTOANTIGEN ASSOCIATED DISEASES AMRAD CORPORATION LIMITED (AU) 1993-12-08 EP disclosed
WO-1992014485-A1 A METHOD FOR THE DIAGNOSIS AND TREATMENT OF GLUTAMIC ACID DECARBOXYLASE AUTOANTIGEN ASSOCIATED DISEASES AMRAD CORPORATION LIMITED (AU) 1992-09-03 WO disclosed
CN-85101907-A The manufacturing of single segment dominent human r gamma-interferon 1987-01-10 CN disclosed